Primary Record
leukotriene E4
- In stock
- 5,006 g
- Purity
- 99.1 %
- CAS
- 75715-89-8
Compound Identifiers & Properties
- CAS
- 75715-89-8
- PubChem CID
- 5280879
- SMILES
- CCCCC/C=C\C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)SC[C@@H](C(=O)O)N
- Canonical SMILES
- CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SC[C@H](N)C(=O)O)[C@@H](O)CCCC(=O)O
Names & Synonyms
- leukotriene E4
- Leukotriene E
- LTE4
- Leukotriene E 4
- Leukotriene E-4
- Leukotrienes E
- 75715-89-8
- LEUKOTRIENEE4
- Leukotriene E(4)
- 8EYT8ATL7G
- AC1NQXPM
- UNII-8EYT8ATL7G
- LEUKOTRIEN E4
- starbld0009611
- 20-OH-Leukotriene E4
- RefChem:924691
- CHEBI:15650
- D0C0KJ
- D0Z3BL
- Epitope ID:688612
- DTXSID20897510
- [3H]LTE4
- 20-Hydroxy-leukotriene E4
- C23H37NO5S
- CHEMBL509456
- OTZRAYGBFWZKMX-FRFVZSDQSA-N
- LTE-4
- BSPBio_001370
- LEUKOTRIENE E4 [MI]
- GTPL3352
- GTPL5863
- orb1690285
- SCHEMBL11263165
- DTXCID801326865
- HMS3402E12
- ZINC4629873
- C23-H37-N-O5-S
- 1826AH
- BDBM50297387
- LMFA03020002
- MFCD00151083
- AKOS040758330
- CID5280879
- CID:5280879
- NCGC00163400-01
- NCGC00163400-02
- DA-64930
- PD119335
- SID:96099805
- Leukotriene E4 Lipid Maps(R) MS Standard
- HY-113465
- J264.600E
- 5S-hydroxy,6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid
- CS-0061845
- NS00074205
- C05952
- G91551
- 29819-EP2272832A1
- 29819-EP2281815A1
- 29819-EP2305640A2
- 29819-EP2311832A1
- 29819-EP2311833A1
- A962255
- D017999
- Q2705859
- (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-2-carboxyethyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyeicosa-7,9,11,14-tetraenoate
- (7E,9E,11Z,14Z)-(5S,6R)-6-(Cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoate
- 5S-Hydroxy-6R-(S-cysteinyl)-7E,9E,11Z,14Z-eicosatetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-(((R)-2-Amino-2-carboxyethyl)thio)-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid
- 7,9,11,14-Eicosatetraenoic acid, 6-((2-amino-2-carboxyethyl)thio)-5-hydroxy-, (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-
- 7,9,11,14-Eicosatetraenoicacid, 6-[[(2R)-2-amino-2-carboxyethyl]thio]-5-hydroxy-, (5S,6R,7E,9E,11Z,14Z)-
- (5S,6R,7E,9E,11Z,14Z)-6-(2-AMINO-2-CARBOXYETHYL)SULFANYL-5-HYDROXYICOSA-7,9,11,14-TETRAENOIC ACID
- (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-(Cysteine-S-yl)-5-hydroxy-7,9,11,14-icosatetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-(L-cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-5-Hydroxy-6-[[(R)-2-amino-2-carboxyethyl]thio]-7,9,11,14-icosatetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-((2-amino-2-carboxyethyl)sulfanyl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-((2R)-2-amino-2-carboxyethyl)sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-((2R)-2-amino-3-hydroxy-3-oxopropyl)sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid
- (5S,6R,7E,9E,11Z,14Z)-6-(cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoic acidS-{(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl}-L-cysteine
- (5S,6R,7E,9E,11Z,14Z)-6-[[(2R)-2-Amino-2-carboxyethyl]thio]-5-hydroxy-7,9,11,14-eicosatetraenoic Acid
- (5S,6R,7E,9E,11Z,14Z)-6-[[(R)-2-Amino-2-carboxyethyl]thio]-5-hydroxy-7,9,11,14-icosatetraenoic acid
- [5S-[5R*,6S*(S*),7E,9E,11Z,14Z]]- 6-[(2-amino-2-carboxyethyl)thio]-5-hydroxy-7,9,11,14-Eicosatetraenoate
- [5S-[5R*,6S*(S*),7E,9E,11Z,14Z]]- 6-[(2-amino-2-carboxyethyl)thio]-5-hydroxy-7,9,11,14-Eicosatetraenoic acid
- S-((1R,2E,4E,6Z,9Z)-1-((1S)-4-carboxy-1-hydroxybutyl)pentadeca-2,4,6,9-tetraen-1-yl)-L-cysteine
- S-{(1R,2E,4E,6Z,9Z)-1-[(1S)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl}-L-cysteine